Topline results from RISE3 are expected in H2 2026.

SALT LAKE CITY (ABC4) — Intermountain Health neurologists are celebrating a major surgical milestone: the 100th use of an implantable device that reduces seizure activity in patients with focal ...

Biohaven Ltd. (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development, and ...

Prior to being diagnosed with epilepsy, 5% of people with a type of epilepsy called focal epilepsy had a seizure while driving, according to a new study published in the June 7, 2023, online issue of ...

Biohaven announced a series of scientific leadership changes, including the upcoming transition of Bruce Car, Ph.D., to Chief ...

Please provide your email address to receive an email when new articles are posted on . Seizure freedom was observed by 12 months and continued past 48 months of the open-label extension. Long-term ...

What is a Focal Seizure? All seizures occur due to abnormal electrical activity in the brain. When the seizure originates at one side of the brain and remains confined within a limited area, it is ...

Focal epilepsy is commonly pharmacoresistant, and resective surgery is often contraindicated by proximity to eloquent cortex. Many patients have no effective treatment options. Gene therapy allows ...